Murat Karacorlu, MD, Hakan Ozdemir, MD, Serra Arf Karacorlu, MD – Istanbul Retina Institute, Inc. Istanbul, Turkey


To report the effects of intravitreal triamcinolone acetonide in a patient with an idiopathic macular hole.


A 55-year-old woman who suffered from an idiopathic macular hole received an intravitreal injection of 4 mg of triamcinolone acetonide.


By the first month after intravitreal triamcinolone acetonide had been injected the hole was closed, her visual acuity was increased from 20/100 to 20/32. Optical coherence tomography showed a normal foveolar depression with a normal photoreceptor layer in the fovea.


Intravitreal injections of triamcinolone acetonide may be an additional tool for the treatment of idiopathic macular holes.

Take-home message:

Triamcinolone acetonide may play a role in the treatment of macular pseudocysts.